These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 576530)

  • 1. The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia.
    Mosekilde L; Christensen MS; Lund B; Sorensen OH; Melsen F
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):559-65. PubMed ID: 576530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and morphometric bone changes in anticonvulsant osteomalacia. Therapeutic effect of vitamin D2.
    Melsen F; Mosekilde L; Christensen MS; Lund B; Sorensen OH
    Calcif Tissue Res; 1977 May; 22 Suppl():473-8. PubMed ID: 303141
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of long-term vitamin D2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia.
    Mosekilde L; Melsen F; Christensen MS; Lund B; Sorenson OH
    Acta Med Scand; 1977; 201(4):303-7. PubMed ID: 300547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of anticonvulsant osteomalacia in epileptic patients on phenytoin treatment.
    Rodbro P; Christiansen C; Lund M
    Acta Neurol Scand; 1974; 50(4):527-32. PubMed ID: 4851341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis of anticonvulsant osteomalacia in adults (author's transl)].
    Krause KH; Prager P; Schmidt-Gayk H; Ritz E
    Dtsch Med Wochenschr; 1977 Dec; 102(51):1872-7. PubMed ID: 598289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy. Short-term effect of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol.
    Mosekilde L; Hansen HH; Christensen MS; Lund B; Sørensen OH; Melsen F; Norman AW
    Acta Med Scand; 1979; 205(5):405-9. PubMed ID: 443080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant osteomalacia determined by quantitative analysis of bone changes. Population study and possible risk factors.
    Mosekilde L; Melsen F
    Acta Med Scand; 1976; 199(5):349-55. PubMed ID: 1274672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phenytoin on bone and vitamin D metabolism.
    Bell RD; Pak CY; Zerwekh J; Barilla DE; Vasko M
    Ann Neurol; 1979 Apr; 5(4):374-8. PubMed ID: 220903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs.
    Stamp TC; Round JM; Rowe DJ; Haddad JG
    Br Med J; 1972 Oct; 4(5831):9-12. PubMed ID: 4342760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children.
    Tolman KG; Jubiz W; Sannella JJ; Madsen JA; Belsey RE; Goldsmith RS; Freston JW
    Pediatrics; 1975 Jul; 56(1):45-50. PubMed ID: 1161362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant drug-induced osteomalacia: alterations in mineral metabolism and response to vitamin D3 administration.
    Hahn TJ; Halstead LR
    Calcif Tissue Int; 1979 Mar; 27(1):13-8. PubMed ID: 223750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteomalacia and anticonvulsant therapy: serum assay of 25 hydroxy D in an epileptic population (author's transl) (proceedings)].
    Ribot C; Geraud G; Castignol M; Dero M; Geraud J; Boulard C
    Ann Endocrinol (Paris); 1976; 37(6):483-4. PubMed ID: 1026169
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteomalacia accompanying chronic anticonvulsant therapy.
    Genuth SM; Klein L; Rabinovich S; King KC
    J Clin Endocrinol Metab; 1972 Sep; 35(3):378-86. PubMed ID: 5051360
    [No Abstract]   [Full Text] [Related]  

  • 14. Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.
    Jungert A; Neuhäuser-Berthold M
    Nutr Res; 2013 Aug; 33(8):661-7. PubMed ID: 23890356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity.
    Mosekilde L; Melsen F; Hessov I; Christensen MS; Lund BJ; Lund BI; Sørensen OH
    Gut; 1980 Jul; 21(7):624-31. PubMed ID: 7429327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunoreactive parathyroid hormone and 25-hydroxyvitamin D in patients with uremic bone diseases.
    Shen F-H ; Baylink DJ; Sherrard DJ; Shen L; Maloney NA; Wergedal JE
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1009-17. PubMed ID: 1133150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [4 cases of osteomalacia during anticonvulsant or sedative treatment].
    Alcalay M; Amor B; Bontoux D; Cayla J; Charbonnier A; Mery C; Rondier J; Miravet L
    Sem Hop; 1975 Dec; 51(49):3019-27. PubMed ID: 174222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia.
    Christiansen C; Rodbro P; Munck O
    Br Med J; 1975 May; 2(5967):363-5. PubMed ID: 165857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study.
    Krishnamoorthy G; Nair R; Sundar U; Kini P; Shrivastava M
    Neurol India; 2010; 58(2):213-9. PubMed ID: 20508338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone composition and vitamin D after Pólya gastrectomy.
    Tougaard L; Rickers H; Rödbro P; Thaysen EH; Christensen MS; Lund B; Sörensen OH
    Acta Med Scand; 1977; 202(1-2):47-50. PubMed ID: 899882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.